Corvus Pharmaceuticals Inc (CRVS) is near the top in its industry group according to InvestorsObserver. CRVS gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Corvus Pharmaceuticals Inc gets a 73 rank in the Biotechnology industry. Biotechnology is number 67 out of 148 industries.
CRVS has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on CRVS!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Corvus Pharmaceuticals Inc Stock Today?
Corvus Pharmaceuticals Inc (CRVS) stock is trading at $1.06 as of 10:49 AM on Tuesday, Jun 7, a rise of $0.04, or 3.92% from the previous closing price of $1.02. The stock has traded between $1.00 and $1.06 so far today. Volume today is light. So far 15,644 shares have traded compared to average volume of 192,065 shares.
Click Here to get the full Stock Report for Corvus Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
